Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (19)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by FLYNN, P. J.
Right arrow Articles by HUGHES, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FLYNN, P. J.
Right arrow Articles by HUGHES, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 1984, Vol. 56, No. 6 599-605
© 1984 The Board of Management and Trustees of the British Journal of Anaesthesia

other

USE OF ATRACURIUM IN CAESAREAN SECTION

P. J. FLYNN, M. FRANK and R. HUGHES

Anaesthetics Uni, The London Hospital Medical College Whitechapel, London E1 IBB
Clinical Research Diviation, Wellcome Reseach Laboratories Beckenham, Kent BR3 3BS

Reprint srequests to R.H.

Correspondence to P. J. F

Following induction of anaesthesia with methohexitone, and tracheal intubation facilitated by suxamethonium, atracurium 0.3 mg kg–1 was administered to 53 partients undergoing Caesarean section. surgical relaxation and cardiovascular blockade occured spontaneously in 45 patients and in the remaining eight patients, neostigmine and stropine produced rapid and effective antagonism. There was no evidence on recuraraization in any patient. In the neonates there were no adverse effects on Apgar scores or on the time to sustained respiration atributable to the use of atracurium. The drug concentration in the umbilical vein measured in 15 patients indicated that atracurium did not cross the placenta in amounts likely to be of clinical significance.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.